Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 611,100 shares, a growth of 26.9% from the September 15th total of 481,700 shares. Based on an average trading volume of 110,100 shares, the short-interest ratio is presently 5.6 days. Currently, 2.0% of the shares of the company are sold short.

Bioceres Crop Solutions Stock Performance

Shares of BIOX stock traded up $0.06 during trading on Friday, reaching $7.51. 130,720 shares of the company's stock were exchanged, compared to its average volume of 77,111. The firm's fifty day moving average price is $9.19 and its 200-day moving average price is $10.70. Bioceres Crop Solutions has a twelve month low of $7.35 and a twelve month high of $14.05. The stock has a market capitalization of $471.61 million, a PE ratio of 751.00 and a beta of 0.47. The company has a quick ratio of 0.91, a current ratio of 1.28 and a debt-to-equity ratio of 0.35.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. The business had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. As a group, sell-side analysts anticipate that Bioceres Crop Solutions will post 0.39 EPS for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of hedge funds have recently bought and sold shares of the company. Long Focus Capital Management LLC raised its position in shares of Bioceres Crop Solutions by 19.9% during the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock worth $3,145,000 after purchasing an additional 46,647 shares during the period. Fourth Sail Capital LP grew its holdings in shares of Bioceres Crop Solutions by 20.5% during the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company's stock valued at $21,992,000 after buying an additional 334,195 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after acquiring an additional 5,341 shares in the last quarter. Ping Capital Management Inc. bought a new position in Bioceres Crop Solutions in the 2nd quarter valued at about $448,000. Finally, Oak Family Advisors LLC boosted its stake in Bioceres Crop Solutions by 1.9% during the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company's stock valued at $728,000 after purchasing an additional 1,208 shares during the last quarter. Institutional investors own 17.68% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on BIOX shares. Roth Mkm reduced their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a report on Wednesday, September 11th. Lake Street Capital dropped their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating for the company in a report on Wednesday, September 11th. Canaccord Genuity Group upgraded Bioceres Crop Solutions to a "strong-buy" rating in a research report on Friday, July 19th. Canaccord Genuity Group cut their price objective on Bioceres Crop Solutions from $17.00 to $12.50 and set a "buy" rating for the company in a report on Wednesday, September 11th. Finally, Oppenheimer lowered their target price on shares of Bioceres Crop Solutions from $17.00 to $16.00 and set an "outperform" rating on the stock in a report on Wednesday, September 11th. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $13.63.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.